Published in Hematology Week, July 27th, 2009
"First published April 9, 2009; doi:10.1152/japplphysiol.90516.2008.-The purpose of this study was to evaluate the involvement of central angiotensin II (ANG II) and ANG II type 1 (AT(1)) receptors in systemic release of arginine vasopressin (AVP) and blood pressure regulation during endotoxemia. LPS (150 mu g/kg) was injected intravenously 30 min after intracerebroventricular (icv) losartan (50 mu g), an AT(1) receptor antagonist,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.